We established a radiation-induced murine hematopoietic cell line, Y6, that could be induced to differentiate into macrophages by interleukin-6 (IL-6). IL-6 also induced growth inhibition and apoptosis in Y6 cells. Retinoic acid (RA) inhibited such effects of IL-6 on Y6 cells. The inhibitory effect of RA on the effects of IL-6 was not caused by the downregulation of the IL-6 receptor, because RA neither affected the expression of IL-6 receptor mRNA nor the expression of IL-6 receptor molecule on the cell surface. Furthermore, RA did not inhibit the IL-&induced expression of iunB mRNA, indicating that the expression of functionally active IL-6 receptor and the signal transduction pathway activating the iunB NTERLEUKIN-6 (IL-6) is a multifunctional cytokine I involved in hematopoiesis, immune response, and acute phase reacti~n."~ IL-6 acts on a variety of cells and induces either cell growth, growth inhibition, or cell differentiation. In fact, IL-6 is a potent growth factor for multiple myeloma and pla~macytoma,~-~ whereas IL-6 inhibits the cell growth and induces macrophage differentiation in a murine myeloid leukemia cell line, M1.'"J1 IL-6 can exert its action through the IL-6 receptor that consists of at least two molecules, an 80-Kd IL-6 receptor a-chain and a signal transducer, g~1 3 0 . '~-'~ The IL-6 signal is transduced through the g~1 3 0~~J~ by activating both tyrosine kinase and H7-sensitive kinase leading to the transcription of immediate early response genes, such as thejunB and Tis11 genes.I6.l7 One of the important activities of IL-6 is that IL-6 acts on myeloid leukemic cells and induces their differentiation into macrophages accompanied by growth arrest.l[lJ1 IL-& induced differentiation of leukemic cells is an ideal model to elucidate the molecular mechanisms of cell differentiation and growth control.
gene are not inhibited by RA. IL-&induced macrophage differentiation of Y6 cells was preceded by the downregulation of the c-myc gene, which was also prevented by RA. Because the inhibitory effect of RA on Y6 cells was reversible and seemed not to require de novo protein synthesis, the RA receptor by itself might be directly involved in the inhibition of the IL-6 signal transduction pathway. The results indicated that the IL-6 signal transduction pathways leading to the induction of macrophage differentiation and iunB gene expression can be dissected by RA.
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inhibitor. We examined the effects of several reagents, including retinoic acid (RA), on IL-&induced macrophage differentiation. RA has been known as an antineopla~tic,~~ anti-inflammatic,20 and differentiation-inducing agent.21-23 Furthermore, RA was reported to inhibit the AP-1-mediated induction of a variety of genes, including the genes belonging to the collagenase family.24 Because IL-6 can induce J u~B ,~~,~~ a component of AP-1, RA may function as an IL-6 inhibitor. Here we report that RA can inhibit IL-&induced macrophage differentiation and c-myc gene downregulation without interfering with the IL-6 signal transduction pathway activating the junB gene in a newly established murine hematopoietic cell line, Y6.
MATERIALS AND METHODS

Reagents.
Recombinant human IL-6 (5 x lo6 U/mg)25 was provided by Ajinomoto (Tokyo, Japan). RA, 12-0-tetradecanoyl phorbol-13-acetate (TPA) and cycloheximide (CHX) were purchased from Sigma Chemical (St Louis, MO), and dimethyl sulfoxide (DMSO) and 5-azacytidine from Wako Pure Chemical (Osaka, Japan). RA and TPA were dissolved in DMSO and 5-azacytidine in the mixture of acetic acid and water (1:1 vollvol), and they were stored at -20°C. The monoclonal antibodies (MoAbs) to Fc receptors (2.4(32),% Mac-la (M1170.15.11.5), 27 and Thyl.2 (BioMaker, Rehovot, Israel) were kindly provided by Dr S. Ono (Osaka University Medical School, Osaka, Japan). Rabbit antimouse IL-6 receptor antiserum was made by immunizing rabbit with recombinant mouse soluble IL-6 receptor. 28 A cell line Y6 was established from spleen cells of BALB/c mice by X-irradiation. Briefly, single cell suspensions of the X-irradiated spleen cells were inoculated at 5 x lo4 cellslwell in 96-well flat-bottom microtiter plates and cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS) and 0.05 kmol/L 2-mercaptoethanol in air with 5% C02 at 37°C. Cultures were fed three times a week by replacing a half of the medium with fresh one. Colonies consisting of nonadherent round cells appeared in about 10% of wells and proliferated vividly. After several times of limiting dilution, we selected several lines that could differentiate into macrophages with IL-6 treatment. One of them was named Y6 and used for further analysis. Y6 line was maintained by adding fresh medium at intervals of 2 or 3 days. The doubling time was estimated as 16 hours. At the time of writing, Y6 line was 24 months old.
Analysis of surface phenotype. Cell surface phenotype was examined by an indirect or direct immunofluorescence technique as described p r e v i o~s l y .~~ Briefly, cells were incubated with either anti-B220,30 anti-Macla, or anti-Fc receptor for 30 minutes on ice,
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and washed three times with phosphate-buffered saline (PBS) containing 2% FCS and 0.02% NaN3. The cells were then incubated with fluorescein-labeled mouse anti-rat Ig (Tago, Burlingame, CA) for 30 minutes on ice. The expression of BP-l3I or Thyl.2 was examined with fluorescein isothiocyanate (F1TC)-labeled antibodies. To examine the expression of mouse IL-6 receptor, F(ab')a fragment of the rabbit anti-mouse soluble IL-6 receptor antibodies (IgG fraction) was prepared. As a control antibody, F(ab')z fragment of normal rabbit IgG was used. Fluorescein-labeled goat anti-rabbit IgG (Tago, Burlingame, CA) was used as a second antibody. After washing three times, the cells were evaluated for membrane immunofluorescence using a FACScan (Becton Dickinson, Mountain View, CA).
Cell proliferation assay. To quantify the proliferation of cells, RNAs were prepared by guanidine thiocyanate method and polyA+ RNAs were prepared by oligo-dT-cellulose column chromatography. RNA samples were electrophoresed in 1% agarose-formaldehyde gels and transferred to a Gene Screen Plus membrane (NEN Research Products, Boston, MA). Hybridization was performed overnight at 65°C in the presence of 0.5 mmol/L NaP04,l mmol/L EDTA, 7% SDS, and 1% bovine serum albumin, using 1 x lo6 cpm/mL of 32P-labeled probe prepared by multiprime DNA labeling system (Amersham, Arlington Heights, IL). Blots were washed with 0.1 x SSC (1 x SSC is 0.15 mol/L NaCl plus 0.015 mol/L sodium citrate)-0.1% SDS at 5 5 T , and subjected to autoradiography. The probes used were as follows: c-myc (1.6 kb, the third exon, MI-Hind111 fragment),16 junB (2.1 kb, EcoRI fragment),16 the B gene isolated from Chinese hamster ovary cells (CHO-B; 0.6 kb, EcoRI-BamHI frag~nent),'~.~~ and mouse IL-6 receptor (0.6 kb, EcoRI-BamHI fragment).36 CHO-B was used as an internal standard for normalization of RNA samples.
Morphologic analysis.
Analys3 of DNA fragmentation.
Northern blot.
RESULTS
ZL-6induced macrophage differentiation and growth inhibition of Y6 cells.
We established a murine hematopoietic cell line, Y6, from irradiated spleen cells. Y6 cells showed blastoid features with basophilic cytoplasm and large nuclei containing nucleoli (Fig lA, upper panel) and were negative for B220, BP-1, Thyl.2, and Mac-la (data not shown), but were faintly positive for Fc receptor (Fig lB, upper  panel) . We could not detect peroxidase and esterase activity in Y6 cells by cytochemistry. These findings indicated that Y6 cells belong to a typical immature hematopoietic lineage. To demonstrate whether Y6 cells retain the ability to differentiate into certain hematopoietic lineage cells, we examined whether TPA, RA, vitamin D3, DMSO, and IL-6 can induce differentiation of Y6 cells. Among them, only IL-6 induced the differentiation of Y6 cells into macrophage-like cells, characterized by large amounts of cytoplasm with vacuoles, irregularly shaped nuclei, and phagocytic activity (Fig lA, lower panel) . Moreover, on the stimulation with IL-6, Y6 cells became positive for esterase activity (data not shown) and showed an increase in Fc receptor expression (Fig lB, lower panel) , but remained negative for B220, BP-1, Thy 1.2, and Mac-la (data not shown). The IL-6-induced macrophage differentiation was accompanied by the inhibition of cell growth (Fig 1C) .
RA prevented IL-6induced macrophage differentiation and growth inhibition. To search for a reagent that could inhibit the activity of IL-6, we examined the effect of TPA, DMSO, vitamin D3, 5-azacytidine, and RA on IL-6-induced growth inhibition of Y6 cells. For this purpose, Y6 cells were treated with one of these reagents for 48 hours and stimulated with IL-6 in the continuous presence of the reagent for 3 days and the cell growth was examined. As shown in Fig 2, only RA significantly prevented the IL-6-induced growth inhibition. As shown in Fig 3A, the cell recovery of Y6 cells stimulated with IL-6 was significantly reduced on days 3 and 4, and the viability of Y6 cells was only 5% 3 days after IL-6 stimulation, indicating that IL-6 induced cell death. However, the cells that were treated with RA for 48 hours and further stimulated with IL-6 in the presence of RA showed continuous cell growth at least until day 4. RA also prevented IL-6-induced macrophage differentiation in Y6 cells. As shown in Fig 3B, 60% of Y6 cells were found to be at intermediate monocyte stages of differentiation on day 2 and 95% of alive cells, mature macrophages on day 3 after the treatment with IL-6. However, a few macrophage-like cells were observed on day 2, and only 25% of Y6 cells were identified to be at intermediate monocyte stages of differentiation, when Y6 cells were treated with RA for 48 hours and stimulated with IL-6 in the presence of RA. Moreover, RA prevented IL-6-induced increase in Fc receptor expression (data not shown). IL-&induced macrophage differentiation of a murine myeloid leukemia cell line, M1, was also inhibited by RA (after exposure to IL-6 for 2 days, 45% of M1 cells and 9.4% of those treated with RA showed macrophagelike cells). For the maximum inhibitory effect of RA on IL-6-induced macrophage differentiation of Y6 cells, Y6 cells were required to be treated with RA for 24 hours with IL-6 was analyzed by gel electrophoresis. Thc DNA obtained from Y6 cells cultured with IL-6 for 36 hours showed the extensive degradation with oligonuclcosomal fragments, which was characteristic of apopto~is.~'.~~ The laddcr of DNA fragments was dctcctablc within 24 hours aftcr IL-6 stimulation ( Fig 4A) . The morphologic features of apoptosis such as the distinctive condensation of chromatin and fragmcnted n u c h P were obscrvcd on MayGriinwald-Gicmsa stained cytospin preparations of IL-6 stimulated Y6 cclls (Fig 4B) . However, if Y6 cells were
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c"e (dyr) Cullure (day.) For personal use only. on April 5, 2017. by guest www.bloodjournal.org From RA did not downregulate IL-6 receptor mRNA expression nor IL-b-induced expression of mRNA for junB. To examine the possibility that the inhibition of IL-6 action by RA was caused by the downregulation of IL-6 receptor expression, we examined the effect of RA on IL-6 receptor mRNA expression. As shown in Fig 5A, for junE. Y6 cells were treated with or without 1 pmol/L RAfor 2 days and stimulated with or without 500 U/mL IL-6 in the presence of RA for 1 hour. Total RNAs were extracted and subjected to Northern blot analysis using UP-labeled junE probe (15 pg per lane).
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For personal use only. on April 5, 2017. by guest www.bloodjournal.org From was significantly downregulated after 6 hours and became undctcctablc after 12 hours. However, if Y6 cells were treated with RA for 2 days and subjected to the stimulation with IL-6 in the presence of RA, the expression of c-myc mRNA was not reduced (Fig 6) .
Efect of RA on the c-myc gene txpression did not require de novo protein synthesis. To determine whether new protein synthesis is required for the inhibitory effect of RA on the IL-&induced downregulation of the c-myc gene, Y6 cells were treated with RA in the presence or absence of 20 pg/mL CHX for 12 hours. The cells were washed out to remove CHX and RA before the stimulation with IL-6, because Y6 cells could not survive the exposure to CHX for more than 12 hours. RNA was extracted from Y6 cells 12 hours after IL-6 stimulation and subjected to Northern blot analysis. As shown in Fig 7, the steady-state levels of the c-myc mRNA were downregulated by IL-6, but RA treatment significantly inhibited the IL-&induced downrcgulation of c-myc mRNA expression. The inhibitory effect of RA on the expression of c-myc mRNA was not complete, because RA was required to be present during the IL-6 treatment for its maximum effect on the IL-6 actions. 3sS-methionine uptake by Y6 cells treated with CHX for 12 hours was suppressed by more than 91% as compared with that of nontreated Y6 cells [(744 2 35) x 104 cpm in 5 X le5 nontreatcd, (64 2 4.1) x 104 cpm in CHX-treated Y6 cells]. However, CHX did not significantly reduce the inhibitory effect of RA on the IL-&induced downrcgulation of the c-myc gene. The data suggested that new protein synthesis may not be required for the action of RA.
DISCUSSION
During the process of macrophage differentiation, pluripotent hematopoietic stem cells become committed to macrophage precursor cells and eventually differentiate into functionally, morphologically distinct end-stage macrophages. This process is accompanied by the coordinate expression of numerous genes that code proteins necessary for cellular proliferation, differentiation, and specific functions of macrophages. IL-6 has been known as a potent inducer of macrophage differentiation of a murine myeloid leukemic cell line M1
We established a murine hcmatopoictic cell line Y6 from irradiated murine spleen cells, and showed that IL-6 induced the differentiation of Y6 cells into macrophages. Furthermore, IL-6 inhibited cell growth of Y6 cells by inducing apoptosis. One of the interesting findings in this study was the fact that RA prevented IL-&induced macrophage differentiation and apoptosis.
RA has been shown to induce differentiation in a variety of cells, including a human promyclocytic leukemia cell line, HL-600,23 and a murine teratocarcinoma cell line, F9.?' The inhibitory effect of RA on the IL-&induced macrophage differentiation was not caused by the change of the differentiation stage of Y6 cells caused by RA, because even when Y6 cells were treated with RA as long as 7 days, they still retained the ability to respond to IL-6 and differentiate into macrophages if RA was removed from the cult urc.
Because RA can downrcgulate the expression of IL-6 receptor in myelomas and hybridomas,J5 RA-mediated inhibition of the IL-&induced macrophage differentiation of Y6 cells could be caused by the downregulation of the expression of IL-6 receptor. However, we showed that neither the expression of IL-6 receptor mRNA nor the expression of IL-6 receptor molecule on the cell surface was inhibited by RA in Y6 cells. Furthermore, RA did not inhibit the IL-&induced expression of the junB gene, clearly indicating that the expression level of functionally active IL-6 receptor was not affected by RA. The data indicate that RA has no effect on the expression of the IL-6 receptor gene and IL-6 receptor-mediated signal transduction pathway activating the junB gene, although RA can interfere with the signal transduction pathway cssential for macrophage differentiation.
There was an interesting relationship between macrophage differentiation and the downregulation of the c-myc gene expression. IL-6 could downrcgulate the c-myc gene cxpression, which preceded macrophage differentiation. 
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kcmia ccll line.4' Morcovcr, antiscnsc myc sequences could inducc thc diffcrcntiation of F9 C C I I S .~~ In a murinc crythrolcukcmia ccll line with the stably transfcctcd rat c-myc gcnc whose cxprcssion was under the control of thc human mctallothioncin I1 gcnc promotcr, the dcgrcc of the DMSOinduccd diffcrcntiation was shown to bc well correlated with thc cxprcssion lcvcls of thc transfcctcd c-myc gcnc that could be modulated by the Zn2+ ion.Jf Hoffman-Licbcrmann and L i~b c r m a n n~~ rcportcd that MI cells, when transfccted with thc c-myc gcne cxprcssion vcctor, could not bc induccd to tcrminally diffcrcntiatc by IL-6 and stayed at an intcrmediatc stage in the progrcssion from immature blasts to mature macrophagcs. In fact, only a fcw mature macrophagcs were gcncratcd from Y6 cclls in thc prescncc of RA and IL-6 for 3 days. The inhibitory cffcct of RA on the IL-binduccd diffcrcntiation into macrophagcs might bc causcd by thc inhibition of thc IL-binduccd downrcgulation of the c-myc gcnc.
De novo protcin synthesis was not rcquircd for the inhibitory cffcct of RA on the IL-Ginduccd downrcgulation of the c-myc gcnc and thc inhibitory cffcct of RA on the IL-6 action was revcrsiblc, suggcsting that activatcd RA receptor may dircctly intcrferc with thc IL-6 signal transduction pathway lcading to the supprcssion of thc c-myc gcnc cxprcssion without any cffcct on thc signal transduction pathway activating thc jrmB gcnc. It has bccn rcccntly rcportcd that thc rctinoblastoma gcnc products (pRB) could supprcss c-myc Rcsnitzky ct aV7 rcportcd that IL-6 supprcsscd phosphorylation of pRB in
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! I b -18s hcmatopoictic cclls, although dephosphorylation of pRB may not bc dircctly involvcd in thc downrcgulation of thc c-myc gcnc. It is possible that RA may inhibit the action of pRB o r activatcd RA receptor may dircctly act on the rcgulatory region of the c-myc gcne. Altcrnativcly, activatcd RA rcccptor could dircctly interact with and inactivatc transcription factor AP-l.JH-3) In this context, AP-1 was shown to bind a negative regulator of the c-myc gene.51sz As IL-6 induccd JunB, a componcnt of AP-1, in Y6 cells, it might bc tempting to speculate that IL-6 could downreylatc thc c-myc gcnc through thc induction of AP-1 and that RA could inhibit the IL-6 action by inactivating AP-1, although this hypothcsis has yct to bc clucidated.
IL-6 has been suggested to play roles in oncogenesis and inflammation,"Jx whcrcas RA has bccn known as an antioncogenic'" and anti-inflammatory?" agent. It was prcviously shown that RA could inhibit thc growth-inducing activity of IL-6 on myeloma cell lincs by downrcgulating thc cxprcssion of IL-6 rcccptor.4s Hcrc wc rcport that RA can inhibit thc IL-binduccd macrophage diffcrcntiation of a murinc hcmatopoictic ccll line Y6 without intcrfcring with thc cxprcssion of functional IL-6 receptor. Takcn togcthcr, thc cvidcncc may indicate that RA could bc used as an inhibitor of IL-bmcdiatcd effccts.
